Quantitative analysis of prostate tissues, however, revealed that Sag deletion significantly reduced prostate tumor burden, as evidenced by significant reduction of incidence of HGPIN and adenocarcinoma, with a majority of cases being hyperplasia and LGPIN (Fig. 1f&g). Here, SAG is linked to adenocarcinoma.